Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC
- Status
- UNKNOWN
- Phase
- N/A
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
- Status
- TERMINATED
- Phase
- N/A
Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
ITIL-306 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Exhaled Breath Particles in Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
ITIL-168 in Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
- Status
- RECRUITING
- Phase
- NA
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
- Status
- UNKNOWN
- Phase
- PHASE1
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
- Status
- RECRUITING
- Phase
- N/A
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions.
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2